Distribution and regulation of cyclooxygenase‐2 in carrageenan‐induced inflammation

British Journal of Pharmacology - Tập 128 Số 4 - Trang 853-859 - 1999
F. Nantel1, Danielle Denis1, Robert J. Gordon2, Angela Northey1, M. Cirino2, Kathleen M. Metters1, Chi Chung Chan2
1Department of Biochemistry and Molecular Biology, Merck Frosst Center for Therapeutic Research, P.O. Box 1005, Dorval–Pointe–Claire, Québec, H9R 4P8, Canada
2Department of Pharmacology, Merck Frosst Center for Therapeutic Research, P.O. Box 1005, Dorval‐Pointe‐Claire, Québec, H9R 4P8, Canada

Tóm tắt

We characterized the regulation of cyclooxygenase‐2 (COX‐2) at the mRNA, protein and mediator level in two rat models of acute inflammation, carrageenan‐induced paw ædema and mechanical hyperalgesia. Carrageenan was injected in the hind paw of rat at low (paw ædema) and high doses (hyperalgesia). COX‐2 and prostaglandin E2 (PGE2) levels were measured by RT–PCR and immunological assays. We also determined the distribution of COX‐2 by immunohistochemistry. The injection of carrageenan produced a significant and parallel induction of both COX‐2 and PGE2. This induction was significantly higher in hyperalgesia than in paw ædema. This was probably due to the 9 fold higher concentration of carrageenan used to provoke hyperalgesia. Immunohistochemical examination showed COX‐2 immunoreactivity in the epidermis, skeletal muscle and inflammatory cells of rats experiencing hyperalgesia. In paw ædema however, only the epidermis showed positive COX‐2 immunoreactivity. Pretreatment with indomethacin completely abolished the induction of COX‐2 in paw ædema but not in hyperalgesia. These results suggest that multiple mechanisms regulate COX‐2 induction especially in the more severe model. In carrageenan‐induced paw ædema, prostanoid production have been linked through the expression of the COX‐2 gene which suggest the presence of a positive feedback loop mechanism. British Journal of Pharmacology (1999) 128, 853–859; doi:10.1038/sj.bjp.0702866

Từ khóa


Tài liệu tham khảo

ALMEIDA A.P., 1980, Influence of indomethacin and other anti‐inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan‐id inflammation in rats, J. Pharmacol. Exp. Ther., 214, 74

10.1172/JCI118717

10.1006/bbrc.1995.1378

10.3109/00365529709000182

10.1038/sj.bjp.0702387

CHAN C.C., 1995, Pharmacology of a selective cyclooxygenase‐2 inhibitor, L‐745,337: a novel nonsteroidal anti‐inflammatory agent with an ulcerogenic sparing effect in rat and non human primate stomach, J. Pharmacol. Exp. Ther., 274, 1531

10.1096/fasebj.5.9.1907252

10.1016/S0049-0172(97)80049-2

10.1172/JCI116971

10.1016/0005-2760(95)00194-8

10.1016/0014-2999(80)90297-6

JONES D.A., 1993, Molecular cloning of human prostaglandin H synthase type II and demonstration of expression in response to cytokines, J. Biol. Chem., 268, 9049, 10.1016/S0021-9258(18)52976-8

10.1053/gast.1996.v111.pm8690211

KARGMAN S.L., 1995, Expression of prostaglandin G/H synthase‐1 and ‐2 protein in human colon cancer, Cancer Res., 55, 2556

10.1006/bbrc.1993.2506

10.1021/jm970036a

LANE N.E., 1997, Pain management in osteoarthritis: the role of COX‐2 inhibitors, J. Rheumatol., 24, 20

LEE S.H., 1992, Selective expression of mitogen‐inducible cyclooxygenase in macrophage stimulated with lipopolysaccharide, J. Biol. Chem., 267, 25934, 10.1016/S0021-9258(18)35698-9

MNICH S.J., 1995, Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2, J. Immunol., 155, 4437, 10.4049/jimmunol.155.9.4437

10.1074/jbc.272.32.19891

10.1146/annurev.pa.33.040193.002251

OTTERNESS I.G., 1988, Methods in Enzymology, pp

10.1021/jm960803q

10.1084/jem.184.3.883

RANDALL L.O., 1957, A method for measurement of analgesic activity on inflamed tissue, Arch. Intl. Pharmacodyn, 111, 409

10.1038/sj.bjp.0701076

10.1007/978-1-4615-5325-0_24

10.1073/pnas.91.25.12013

10.1073/pnas.95.22.13313

10.1016/0163-7258(91)90054-P

10.1007/s002239900440

10.1038/bjc.1997.192

10.1007/BF01630479

VINEGAR R., 1987, Pathway to carrageenan‐induced inflammation in the hind limb of the rat, Federation Proc., 46, 118

10.1016/0016-5085(94)90074-4

ZHANG Y., 1997, Inhibition of cyclooxygenase‐2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production, J. Pharmacol. Exp. Ther., 283, 1069